Key Points
- Director Timothy Hayes sold 12,000 Health In Tech shares at an average price of $0.91, generating $10,920 and reducing his direct holdings by 9.04% to 120,780 shares. He also sold 5,730 shares earlier in the week.
- Health In Tech shares opened at $0.91, near their 52-week low of $0.85 and below both their 50-day and 200-day moving averages. The company recently reported a quarterly loss of $0.04 per share, missing the $0.03 consensus estimate.
- Analyst sentiment remains mixed: the stock has a “Moderate Buy” consensus rating and a $3.50 average price target, despite one “Sell” rating and a recent target-price reduction from Maxim Group.
Health In Tech, Inc. (NASDAQ:HIT - Get Free Report) Director Timothy Hayes sold 12,000 shares of the business's stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $0.91, for a total value of $10,920.00. Following the sale, the director directly owned 120,780 shares in the company, valued at approximately $109,909.80. The trade was a 9.04% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Timothy Hayes also recently made the following trade(s):
- On Wednesday, September 9th, Timothy Hayes sold 5,730 shares of Health In Tech stock. The shares were sold at an average price of $0.93, for a total value of $5,328.90.
Health In Tech Stock Down 2.7%
Shares of Health In Tech stock opened at $0.91 on Friday. The business has a fifty day simple moving average of $1.04 and a 200-day simple moving average of $1.23. The firm has a market cap of $59.36 million, a price-to-earnings ratio of -12.94 and a beta of 2.72. Health In Tech, Inc. has a fifty-two week low of $0.85 and a fifty-two week high of $4.02.
Health In Tech (NASDAQ:HIT - Get Free Report) last released its earnings results on Thursday, August 13th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.01). The company had revenue of $8.06 million for the quarter.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in HIT. Cubist Systematic Strategies LLC purchased a new position in shares of Health In Tech in the first quarter worth approximately $41,000. Raymond James Financial Inc. purchased a new stake in shares of Health In Tech in the 3rd quarter valued at approximately $45,000. Squarepoint Ops LLC purchased a new stake in shares of Health In Tech in the 3rd quarter valued at approximately $46,000. Jane Street Group LLC acquired a new position in Health In Tech in the 1st quarter worth approximately $48,000. Finally, Millennium Management LLC purchased a new position in Health In Tech during the 3rd quarter worth approximately $85,000.
Wall Street Analysts Forecast Growth
HIT has been the subject of a number of recent research reports. Weiss Ratings reiterated a "sell (d)" rating on shares of Health In Tech in a research report on Tuesday, June 30th. Maxim Group decreased their target price on Health In Tech from $4.00 to $3.00 and set a "buy" rating on the stock in a report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Health In Tech presently has a consensus rating of "Moderate Buy" and an average target price of $3.50.
Read Our Latest Stock Analysis on Health In Tech
About Health In Tech
(
Get Free Report)
Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
